Survivin geneexpression was increased in rats treated with both labelled andunlabelled BM-MSCs, indicating that the tumor remained activedespite treatment with stem cells.Our results were in contrast to anearlier study on a mice model, which demonstrated decreasedsurvivin expression following treatment with MSCs [39]. Here, BIRC5 is linked to neoplasm.